All News #Library
Biotech
Halia Therapeutics Presents At BIO Investment Summit
02 Mar 2026 //
PR NEWSWIRE
Halia Therapeutics Reports Ofirnoflast Success In Lower-Risk MDS
08 Dec 2025 //
PR NEWSWIRE
Halia Therapeutics Unveils Novel NEK7 Inhibitor Data At ASH 2025
10 Nov 2025 //
PR NEWSWIRE
Halia Therapeutics Appoints Paul Jones As Chief Strategy Officer
06 Oct 2025 //
PR NEWSWIRE
Halia Completes Ph1 Study of HT-4253 for Neuroinflammation
16 Jun 2025 //
PR NEWSWIRE

Market Place
Sourcing Support